Bastide Le Confort Médical SA (LON:0IP1)
26.60
-0.05 (-0.19%)
At close: Apr 17, 2025
LON:0IP1 Revenue
Bastide Le Confort Médical had revenue of 275.53M EUR in the half year ending December 31, 2024, with 10.33% growth. This brings the company's revenue in the last twelve months to 540.26M, up 3.24% year-over-year. In the fiscal year ending June 30, 2024, Bastide Le Confort Médical had annual revenue of 529.76M with 4.28% growth.
Revenue (ttm)
540.26M EUR
Revenue Growth
+3.24%
P/S Ratio
0.38
Revenue / Employee
148.63K EUR
Employees
3,635
Market Cap
167.84M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 529.76M | 21.72M | 4.28% |
Jun 30, 2023 | 508.03M | 39.73M | 8.48% |
Jun 30, 2022 | 468.30M | 24.23M | 5.46% |
Jun 30, 2021 | 444.07M | 61.37M | 16.04% |
Jun 30, 2020 | 382.71M | 46.98M | 13.99% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |